Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CF Industries Holdings, Inc. (CF) vs Viatris Inc (VTRS) Price & Performance

CF Industries Holdings, Inc.Trade
Viatris IncTrade

Price performance (Past 24H)

Key statistics

CF Industries Holdings, Inc. vs Viatris Inc — how do they compare? CF Industries Holdings, Inc. trades at $117.34 (market cap $17.83B), while Viatris Inc trades at $16.28 (market cap $18.69B). The key difference: CF Industries Holdings, Inc. and Viatris Inc are close in size by market cap, and Viatris Inc pays the higher dividend (2.95%). Which is the better fit depends on your goals.

CFVTRS
Market Cap
$17.83B$18.69B
Sector
Basic MaterialsHealth
52-Week High
$137.55$17.86
52-Week Low
$76.08$9.49
Enterprise Value
$18.96B$30.80B
Dividend Yield
2.04%2.95%

Returns comparison

Trailing returns across standard periods

About CF Industries Holdings, Inc.

CF Industries is a leading producer and distributor of nitrogen fertilizers. The company operates seven nitrogen facilities in North America and holds joint venture interests in further production capacity in the United Kingdom and Trinidad and Tobago. CF makes nitrogen primarily using low-cost U.S. natural gas as its feedstock, making CF one of the lowest-cost nitrogen producers globally.

Read more on CF

About Viatris Inc

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).

Read more on VTRS